生存率-话题@MedSci

#生存率#

482篇内容 | 2938人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256845, encodeId=2d1c1256845b8, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur J Cancer：单发巨型肝癌根治性切除后无复发生存率和总生存率的新预测模型, objectType=article, longId=215600, objectId=477921560014, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=477921560014, replyNumber=0, likeNumber=62, createdTime=2021-08-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=477921560014, moduleTitle=Eur J Cancer：单发巨型肝癌根治性切除后无复发生存率和总生存率的新预测模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=477921560014)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256844, encodeId=43581256844a8, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=阿司匹林与消化道肿瘤——降低60%发病风险，提高一倍生存率！, objectType=article, longId=215240, objectId=ed892152406e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed892152406e, replyNumber=0, likeNumber=68, createdTime=2021-08-05, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed892152406e, moduleTitle=阿司匹林与消化道肿瘤——降低60%发病风险，提高一倍生存率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed892152406e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256843, encodeId=98551256843d7, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Clin Cancer Res：阿西替尼可显著提高复发/转移性腺样囊性癌的无进展生存率, objectType=article, longId=215074, objectId=bf7d2150e423, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf7d2150e423, replyNumber=0, likeNumber=86, createdTime=2021-08-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf7d2150e423, moduleTitle=Clin Cancer Res：阿西替尼可显著提高复发/转移性腺样囊性癌的无进展生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf7d2150e423)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256842, encodeId=2f3712568426f, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=iFLT-PET/CT是弥漫性大B细胞淋巴瘤化疗免疫治疗后无进展生存率的早期和优越预测指标, objectType=article, longId=215050, objectId=6c75215050c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c75215050c9, replyNumber=0, likeNumber=70, createdTime=2021-07-31, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c75215050c9, moduleTitle=iFLT-PET/CT是弥漫性大B细胞淋巴瘤化疗免疫治疗后无进展生存率的早期和优越预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c75215050c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256841, encodeId=6ad71256841de, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Clin Oncol：5-aza+HSCT可显著提高MDS老年患者的生存率, objectType=article, longId=214570, objectId=899e2145e0f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=899e2145e0f2, replyNumber=0, likeNumber=53, createdTime=2021-07-23, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=899e2145e0f2, moduleTitle=J Clin Oncol：5-aza+HSCT可显著提高MDS老年患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=899e2145e0f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256840, encodeId=3ae51256840cd, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=如何通过内镜检查提高检出率，将患者的生存率从23%提升至80%？, objectType=article, longId=214338, objectId=08a2214338c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08a2214338c8, replyNumber=0, likeNumber=67, createdTime=2021-07-18, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08a2214338c8, moduleTitle=如何通过内镜检查提高检出率，将患者的生存率从23%提升至80%？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08a2214338c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256839, encodeId=72011256839c0, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Br J Cancer：质子泵抑制剂PPI的使用影响结直肠癌患者的生存率, objectType=article, longId=214207, objectId=7a5221420e49, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a5221420e49, replyNumber=0, likeNumber=86, createdTime=2021-07-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a5221420e49, moduleTitle=Br J Cancer：质子泵抑制剂PPI的使用影响结直肠癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a5221420e49)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256838, encodeId=9978125683863, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Prostate：根治性前列腺切除术患者的长期总生存率通常优于普通人群, objectType=article, longId=213154, objectId=5067213154c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5067213154c6, replyNumber=0, likeNumber=0, createdTime=2021-06-25, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5067213154c6, moduleTitle=Prostate：根治性前列腺切除术患者的长期总生存率通常优于普通人群, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5067213154c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256837, encodeId=fc75125683e26, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Netw Open：年轻结直肠癌患者生存率反而更低，这是什么道理？, objectType=article, longId=212869, objectId=3d8121286981, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d8121286981, replyNumber=0, likeNumber=64, createdTime=2021-06-19, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d8121286981, moduleTitle=JAMA Netw Open：年轻结直肠癌患者生存率反而更低，这是什么道理？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d8121286981)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256836, encodeId=04d21256836f9, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JACC：影响复苏抢救过的心脏骤停患者生存率的因素, objectType=article, longId=212656, objectId=79a4212656fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79a4212656fc, replyNumber=0, likeNumber=70, createdTime=2021-06-14, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79a4212656fc, moduleTitle=JACC：影响复苏抢救过的心脏骤停患者生存率的因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79a4212656fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256835, encodeId=68ce12568357f, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=阿司匹林并不能提高COVID-19住院病人的生存率, objectType=article, longId=212523, objectId=f19021252399, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f19021252399, replyNumber=0, likeNumber=61, createdTime=2021-06-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f19021252399, moduleTitle=阿司匹林并不能提高COVID-19住院病人的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f19021252399)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256834, encodeId=ef111256834e7, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Urol：异时性转移激素敏感性前列腺癌男性中恩杂鲁胺和雄激素阻断疗法治疗的总生存率研究 , objectType=article, longId=212266, objectId=dc142122664a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc142122664a, replyNumber=0, likeNumber=58, createdTime=2021-06-05, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc142122664a, moduleTitle=Eur Urol：异时性转移激素敏感性前列腺癌男性中恩杂鲁胺和雄激素阻断疗法治疗的总生存率研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc142122664a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256833, encodeId=ec28125683352, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Brit J Cancer：PALB2突变与前列腺癌风险和生存率的关系, objectType=article, longId=211507, objectId=7f8321150ea1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f8321150ea1, replyNumber=0, likeNumber=75, createdTime=2021-05-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f8321150ea1, moduleTitle=Brit J Cancer：PALB2突变与前列腺癌风险和生存率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f8321150ea1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256832, encodeId=292c1256832a1, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet：PET-CT辅助前列腺癌术后放化疗可有效提高生存率！, objectType=article, longId=211384, objectId=cbc421138415, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbc421138415, replyNumber=0, likeNumber=70, createdTime=2021-05-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbc421138415, moduleTitle=Lancet：PET-CT辅助前列腺癌术后放化疗可有效提高生存率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbc421138415)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256831, encodeId=87231256831f9, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Advanced Science：心脏病发作后，锰增强磁共振或可提高患者生存率, objectType=article, longId=211193, objectId=f5d5211193d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5d5211193d7, replyNumber=0, likeNumber=90, createdTime=2021-05-14, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5d5211193d7, moduleTitle=Advanced Science：心脏病发作后，锰增强磁共振或可提高患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5d5211193d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256830, encodeId=2e61125683046, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Urol Focus：活检格里森等级5组的模式（4+5 vs 5+4 vs 5+5）能够预测根治性前列腺切除术或外照射放疗后的生存率, objectType=article, longId=210912, objectId=9235210912c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9235210912c5, replyNumber=0, likeNumber=80, createdTime=2021-05-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9235210912c5, moduleTitle=Eur Urol Focus：活检格里森等级5组的模式（4+5 vs 5+4 vs 5+5）能够预测根治性前列腺切除术或外照射放疗后的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9235210912c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256829, encodeId=4c5712568293e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=卫健委：中国恶性肿瘤的5年生存率提高近10%, objectType=article, longId=210611, objectId=ed75210611de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed75210611de, replyNumber=0, likeNumber=114, createdTime=2021-04-30, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed75210611de, moduleTitle=卫健委：中国恶性肿瘤的5年生存率提高近10%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed75210611de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256828, encodeId=6d50125682860, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JNNP：早期非典型体征和岛叶低代谢可预测多系统萎缩患者的生存率, objectType=article, longId=210435, objectId=96d921043552, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96d921043552, replyNumber=0, likeNumber=124, createdTime=2021-04-26, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96d921043552, moduleTitle=JNNP：早期非典型体征和岛叶低代谢可预测多系统萎缩患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96d921043552)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256827, encodeId=bb3a125682ec7, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=DCR：围手术期输血与直肠癌切除后总生存率降低有关, objectType=article, longId=210117, objectId=c20f21011e9c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c20f21011e9c, replyNumber=0, likeNumber=77, createdTime=2021-04-19, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c20f21011e9c, moduleTitle=DCR：围手术期输血与直肠癌切除后总生存率降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c20f21011e9c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256826, encodeId=b4e21256826a5, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA：塞来昔布联合FOLFOX标准辅助化疗对结肠癌患者无病生存率的影响, objectType=article, longId=209666, objectId=658c209666ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=658c209666ea, replyNumber=0, likeNumber=71, createdTime=2021-04-09, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=658c209666ea, moduleTitle=JAMA：塞来昔布联合FOLFOX标准辅助化疗对结肠癌患者无病生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=658c209666ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur J Cancer：单发巨型肝癌根治性切除后无复发生存率和总生存率的新预测模型

2021-08-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

阿司匹林与消化道肿瘤——降低60%发病风险，提高一倍生存率！

2021-08-05

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Clin Cancer Res：阿西替尼可显著提高复发/转移性腺样囊性癌的无进展生存率

2021-08-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

iFLT-PET/CT是弥漫性大B细胞淋巴瘤化疗免疫治疗后无进展生存率的早期和优越预测指标

2021-07-31

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Clin Oncol：5-aza+HSCT可显著提高MDS老年患者的生存率

2021-07-23

guoyibin (审核中...)

前往app查看评论内容

#生存率#

如何通过内镜检查提高检出率，将患者的生存率从23%提升至80%？

2021-07-18

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Br J Cancer：质子泵抑制剂PPI的使用影响结直肠癌患者的生存率

2021-07-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Prostate：根治性前列腺切除术患者的长期总生存率通常优于普通人群

2021-06-25

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Netw Open：年轻结直肠癌患者生存率反而更低，这是什么道理？

2021-06-19

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JACC：影响复苏抢救过的心脏骤停患者生存率的因素

2021-06-14

guoyibin (审核中...)

前往app查看评论内容

#生存率#

阿司匹林并不能提高COVID-19住院病人的生存率

2021-06-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Urol：异时性转移激素敏感性前列腺癌男性中恩杂鲁胺和雄激素阻断疗法治疗的总生存率研究

2021-06-05

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Brit J Cancer：PALB2突变与前列腺癌风险和生存率的关系

2021-05-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet：PET-CT辅助前列腺癌术后放化疗可有效提高生存率！

2021-05-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Advanced Science：心脏病发作后，锰增强磁共振或可提高患者生存率

2021-05-14

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Urol Focus：活检格里森等级5组的模式（4+5 vs 5+4 vs 5+5）能够预测根治性前列腺切除术或外照射放疗后的生存率

2021-05-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

卫健委：中国恶性肿瘤的5年生存率提高近10%

2021-04-30

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JNNP：早期非典型体征和岛叶低代谢可预测多系统萎缩患者的生存率

2021-04-26

guoyibin (审核中...)

前往app查看评论内容

#生存率#

DCR：围手术期输血与直肠癌切除后总生存率降低有关

2021-04-19

一叶知秋 (审核中...)

前往app查看评论内容

#生存率#

JAMA：塞来昔布联合FOLFOX标准辅助化疗对结肠癌患者无病生存率的影响

2021-04-09

科室
- - 订阅+
  - 更多科室
工具
服务